Recomendaciones de prevención y tratamiento de tromboembolismo venoso en infección por SARS-CoV-2 / Recommendations for the prevention and treatment of venous thromboembolism in SARS-CoV-2 infection
Rev. Hosp. Clin. Univ. Chile
;
31(3): 198-205, 2020. tab
Artigo
em Espanhol
| LILACS
| ID: biblio-1145376
ABSTRACT
Coronavirus disease (Covid-19) is characterized by an intense inflammatory response and coagulopathy that is associated to a high incidence of thrombotic events with in situ thrombosis of the microcirculation of the lungs and other organs, which is the key event in the pathogenesis of the respiratory and multi-organ failure. These observations have led to to the use of heparin, which has anticoagulant, antiinflammatory and anti-viral properties, as the best agent to treat these patients. Clinical guidelines recommend the use of heparin thromboprophilaxis in these patients, although there is no agreement in the indication, dose and duration of thromboprophylaxis due to lack of randomized studies. (AU)
Texto completo:
DisponíveL
Índice:
LILACS (Américas)
Assunto principal:
Infecções por Coronavirus
/
Tromboembolia Venosa
Tipo de estudo:
Ensaio Clínico Controlado
/
Guia de Prática Clínica
Limite:
Feminino
/
Humanos
/
Masculino
/
Gravidez
Idioma:
Espanhol
Revista:
Rev. Hosp. Clin. Univ. Chile
Assunto da revista:
Medicina
Ano de publicação:
2020
Tipo de documento:
Artigo
País de afiliação:
Chile
Instituição/País de afiliação:
Hospital Clínico de la Universidad de Chile/CL
Similares
MEDLINE
...
LILACS
LIS